PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24060581-6	2014	The aim of this review is to discuss the emerging roles of sphingolipids, both endogenous and dietary, in colon cancer and the interaction of sphingolipids with WNT/beta-catenin pathway, one of the most important signaling cascades that regulate development and homeostasis in intestine.	Sphingolipids	142-155	catenin beta 1	Homo sapiens	165-177	
11559543-0	2001	Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.	Sphingolipids	107-120	catenin beta 1	Homo sapiens	28-40	
11559543-4	2001	Sphingolipid feeding reduced the number of tumors in all regions of the intestine, and caused a marked redistribution of beta-catenin from a diffuse (cytosolic plus membrane) pattern to a more "normal" localization at mainly intercellular junctions between intestinal epithelial cells.	Sphingolipids	0-12	catenin beta 1	Homo sapiens	121-133	
11559543-5	2001	The major digestion product of complex sphingolipids is sphingosine, and treatment of two human colon cancer cell lines in culture (SW480 and T84) with sphingosine reduced cytosolic and nuclear beta-catenin, inhibited growth, and induced cell death.	Sphingolipids	39-52	catenin beta 1	Homo sapiens	194-206	
11559543-7	2001	Thus, dietary sphingolipids, presumably via their digestion products, bypass or correct defect(s) in the APC/beta-catenin regulatory pathway.	Sphingolipids	14-27	catenin beta 1	Homo sapiens	109-121	
20970453-6	2011	Mechanistic studies indicate that sphingolipids regulate particular gene expression by modulating phosphorylation and acetylation of proteins that serve as transcription factors (beta-catenin, Sp1), repressor of transcription (histone H3), and regulators (SRp30a) in RNA splicing.	Sphingolipids	34-47	catenin beta 1	Homo sapiens	179-191